Koers Carl Zeiss Meditec AG Other OTC
Aandelen
CZMWY
US14218T1051
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 2,23 mld. 2,41 mld. | Omzet 2025 * | 2,51 mld. 2,71 mld. | Marktkapitalisatie | 7,83 mld. 8,45 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 255 mln. 275 mln. | Nettowinst (verlies) 2025 * | 312 mln. 337 mln. | EV/omzet 2024 * | 3,69 x |
Nettoschuld 2024 * | 396 mln. 427 mln. | Nettoschuld 2025 * | 345 mln. 372 mln. | EV/omzet 2025 * | 3,26 x |
K/w-verhouding 2024 * |
30,7
x | K/w-verhouding 2025 * |
24,8
x | Werknemers | - |
Dividendrendement 2024 * |
1,21% | Dividendrendement 2025 * |
1,36% | Vrij verhandelbaar | 40,86% |
Recentste transcriptie over Carl Zeiss Meditec AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 31-12-21 |
Director of Finance/CFO | 59 | 01-10-18 | |
Christian Müller
BRD | Director/Board Member | 57 | 15-12-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-01-02 |
Karl Lamprecht
CHM | Chairman | 60 | 25-06-20 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 27-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,88% | 217 mld. | |
+10,63% | 190 mld. | |
+18,16% | 141 mld. | |
+29,70% | 110 mld. | |
+2,09% | 64,8 mld. | |
+14,14% | 52,44 mld. | |
+3,01% | 49,94 mld. | |
+4,64% | 42,63 mld. | |
+1,45% | 35,81 mld. |